PureTech Health (PRTC) Total Liabilities (2019 - 2025)
PureTech Health (PRTC) reported Total Liabilities of $229.0 million for Q4 2025, up 17.63% year-over-year from $194.7 million in Q4 2024, and up 24.33% on a QoQ basis from $184.2 million in Q2 2025.
PureTech Health (PRTC) has 6 years of Total Liabilities data on file, last reported at $229.0 million in Q4 2025.
- Quarterly Total Liabilities rose 17.63% year-over-year to $229.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $229.0 million (up 17.63% YoY) and the FY2025 annual result came in at $229.0 million, up 17.63% from the prior year.
- Total Liabilities grew to $229.0 million in Q4 2025 per PRTC's latest filing, from $184.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $361.9 million in Q4 2021 and bottomed at $155.1 million in Q4 2022.
- The 4-year median for Total Liabilities is $194.7 million (2024), against an average of $225.0 million.
- The widest annual swing landed in 2022, when Total Liabilities sank 57.15%; it then increased 17.63% in 2025.
- Tracing PRTC's Total Liabilities over 4 years: stood at $361.9 million in 2021, then slumped by 57.15% to $155.1 million in 2022, then gained by 25.57% to $194.7 million in 2024, then gained by 17.63% to $229.0 million in 2025.
- Per Business Quant, the three latest PRTC Total Liabilities figures stand at $229.0 million (Q4 2025), $184.2 million (Q2 2025), and $194.7 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 9.45 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 10.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 4.05 Bn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | 229.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 229.03 Mn |
| Jun 30, 2025 | 184.22 Mn |
| Dec 31, 2024 | 194.70 Mn |
| Dec 31, 2022 | 155.06 Mn |
| Dec 31, 2021 | 361.86 Mn |
| Dec 31, 2020 | 336.46 Mn |
| Dec 31, 2019 | 290.78 Mn |